Pancreatic cancer is the fifth leading cause of cancer death in this country and it is almost uniformly fatal. The poor prognosis of pancreatic cancer patients can be attributed to the lack of early detections and effective treatments. Efforts to fight pancreatic cancer have been hampered by the absence of a good animal model of pancreatic cancer. A reliable mouse model is urgently needed. Tremendous progress has been made in understanding the molecular genetics of human pancreatic adenocarcinoma within the last decade. It is now clear that pancreatic cancer is a genetic disease; the tumor-suppressor genes most frequently inactivated include pl6/INK4a and SMAD4/DPC4, while oncogene HER-2/neu/ERBB2 is often overexpressed in human pancreatic adenocarcinoma. This valuable information can be utilized to create mouse models that directly mirror human pancreatic adenocarcinoma. The main objective of the project is to create mouse models of ductal pancreatic adenocarcinoma. Here we propose three complementary strategies to accomplish this goal.
The first aim i s to create a conditionally deleted p16 mouse.
The second aim i s to characterize SMAD4/MT-TGFalpha mice.
Our third aim targets HER-2. HER-2 is upregulated at early stage of pancreatic tumorigenesis. We reason that pancreas-specific expression of HER-2 in a transgenic mouse line would provide the necessary first-hit to complement our p16 and SMAD4 knock-out mice. Our strategies emphasize the uses of conditional gene targeting, which would allow pancreas-specific gene regulation and tumor development, and avoid the development of undesirable phenotypes in mice. The urgency to detect and treat this deadly disease has prompted the NCI to issue a Progress Review Group report, in which the NCI identifies the development of an animal model of pancreatic cancer as one of its research priorities. This proposal is 100% pancreatic cancer relevant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA109525-01
Application #
6811716
Study Section
Special Emphasis Panel (ZRG1-CG (01))
Program Officer
Perry, Mary Ellen
Project Start
2004-09-01
Project End
2009-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
1
Fiscal Year
2004
Total Cost
$264,040
Indirect Cost
Name
Columbia University (N.Y.)
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Yu, Chih-Chieh; Qiu, Wanglong; Juang, Caroline S et al. (2017) Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications. Cancer Lett 384:86-93
García-Carracedo, Darío; Villaronga, Maria Ángeles; Álvarez-Teijeiro, Saúl et al. (2016) Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget 7:29780-93
Qiu, Wanglong; Tang, Sophia M; Lee, Sohyae et al. (2016) Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Gastroenterology 150:218-228.e12
Westphalen, C Benedikt; Takemoto, Yoshihiro; Tanaka, Takayuki et al. (2016) Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis. Cell Stem Cell 18:441-55
Garcia-Carracedo, Dario; Yu, Chih-Chieh; Akhavan, Nathan et al. (2015) Smad4 loss synergizes with TGF? overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis. PLoS One 10:e0120851
Garcia-Carracedo, Dario; Chen, Zong-Ming; Qiu, Wanglong et al. (2014) PIK3CA mutations in mucinous cystic neoplasms of the pancreas. Pancreas 43:245-9
Qiu, Wanglong; Tong, Guo-Xia; Turk, Andrew T et al. (2014) Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma. Biomed Res Int 2014:810487
Gu, Dongsheng; Liu, Hailan; Su, Gloria H et al. (2013) Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther 12:1038-48
Qiu, Wanglong; Su, Gloria H (2013) Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis. Cancer Metastasis Rev 32:83-107
Garcia-Carracedo, Dario; Turk, Andrew T; Fine, Stuart A et al. (2013) Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 19:6830-41

Showing the most recent 10 out of 26 publications